Background Hepatitis B virus (HBV) reactivation is a well-known risk during chemotherapy for hematological malignancies with reported rates ranging between 14% and 72%. However, there is a paucity of data regarding HBV infection management and reactivation risk in patients receiving systemic treatments for solid tumors. Design We conducted a PubMed search for publications from January 1990 until May 2016 related to HBV reactivation.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with P.
Contact P., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack